I 
108TH CONGRESS 
2D SESSION 
H. R. 4882
To amend the Controlled Substances Import and Export Act to provide 
authority to the Attorney General to authorize narcotic drugs in schedule 
I, II, III, or IV and nonnarcotic controlled substances in schedule I 
or II to be exported from the United States to a country for subsequent 
export from that country to another country, if certain conditions are 
met. 
IN THE HOUSE OF REPRESENTATIVES 
JULY 21, 2004
Mr. PITTS (for himself, Mr. BROWN of Ohio, Mr. GREENWOOD, Ms. ESHOO, 
Mr. DEAL of Georgia, Mr. GERLACH, Mr. WELDON of Pennsylvania, Mr. 
CANNON, Mr. MATHESON, Mr. HOUGHTON, Mr. BISHOP of Utah, and 
Mr. CUNNINGHAM) introduced the following bill; which was referred to 
the Committee on Energy and Commerce, and in addition to the Com-
mittee on the Judiciary, for a period to be subsequently determined by 
the Speaker, in each case for consideration of such provisions as fall with-
in the jurisdiction of the committee concerned 
A BILL 
To amend the Controlled Substances Import and Export 
Act to provide authority to the Attorney General to au-
thorize narcotic drugs in schedule I, II, III, or IV and 
nonnarcotic controlled substances in schedule I or II 
to be exported from the United States to a country 
for subsequent export from that country to another coun-
try, if certain conditions are met.
Be it enacted by the Senate and House of Representa-
tives of the United States of America in Congress assembled, 
SECTION 1. SHORT TITLE. 
This Act may be cited as the ‘‘Controlled Substances 
Export Reform Act of 2004’’. 
SEC. 2. REEXPORTATION OF CONTROLLED SUBSTANCES. 
Section 1003 of the Controlled Substances Import 
and Export Act (21 U.S.C. 953) is amended by adding 
at the end the following subsection: 
‘‘(f) Notwithstanding subsections (a)(4) and (c)(3), 
the Attorney General may authorize any narcotic drug in 
schedule I, II, III, or IV or any nonnarcotic controlled sub-
stance in schedule I or II (which drug or substance is re-
ferred to in this subsection as a ‘covered drug’) to be ex-
ported from the United States to a country for subsequent 
export from that country to another country, if each of 
the following conditions is met: 
‘‘(1) Both the country to which the covered 
drug is exported from the United States (referred to 
in this subsection as the ‘first country’) and the 
country to which the drug is exported from the first 
country (referred to in this section as the ‘second 
country’) are parties to the Conventions referred to 
in subsections (a)(1)(C) and (e)(3).
‘‘(2) The first country and the second country 
have each instituted and maintain, in conformity to 
such Conventions, a system of controls of imports of 
controlled substances which the Attorney General 
deems adequate. 
‘‘(3) With respect to the first country, the cov-
ered drug is consigned to a holder of such permits 
or licenses as may be required under the laws of 
such country, and a permit or license to import the 
drug has been issued by the country. 
‘‘(4) With respect to the second country, sub-
stantial evidence is furnished to the Attorney Gen-
eral by the person who will export the covered drug 
from the United States that—
‘‘(A) the drug is to be consigned to a hold-
er of such permits or licenses as may be re-
quired under the laws of such country, and a 
permit or license to import the drug is to be 
issued by the country; 
‘‘(B) there is an actual need for the drug 
for medical, scientific, or other legitimate uses 
within the country; and 
‘‘(C) the drug will not be exported from 
the country.
‘‘(5) Within 30 days after the covered drug is 
exported from the first country to the second coun-
try, the person who exported the drug from the 
United States delivers to the Attorney General docu-
mentation certifying that such export from the first 
country has occurred. 
‘‘(6) A permit to export the covered drug from 
the United States has been issued by the Attorney 
General.’’.
Æ